Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe revision tag at the bottom of the page updated from v3.6.3 to v3.6.4. This indicates a behind-the-scenes update to the ClinicalTrials.gov interface on the study history page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedThe record history now lists Revision: v3.6.3 as the latest version, superseding v3.6.2. This signifies a minor administrative update to the historical record rather than changes to study content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe revision label on the history page updated from v3.6.0 to v3.6.2, indicating a small update to the page’s version; it reflects an internal update rather than changes to the study information.SummaryDifference0.1%

- Check51 days agoChange DetectedThe history now notes that recruitment is closed and records a new revision (v3.6.0). The previous revision label (v3.5.5) has been removed.SummaryDifference0.3%

- Check58 days agoChange DetectedAdded a new revision entry 'Revision: v3.5.5' to the study record history and removed the previous entry 'Revision: v3.5.4'. This updates the page's revision history metadata to reflect the latest version.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.5.4) appears in the Study Record History, superseding the previous v3.5.3. This indicates an update to the record’s metadata rather than substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.